NANTAHALA CAPITAL MANAGEMENT, LLC – Keros Therapeutics, Inc. Transaction History
NANTAHALA CAPITAL MANAGEMENT, LLC portfolio value:
$1.57M
portfolio value
Keros Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -7.26% | -66.20K shares | 6.61M | $37.62 | 845.69K |
Q3 2022 | call | 0.00% | 0 shares | 418K | $37.62 | 41.9K | |
Q2 2022 | share | Increase | +11.64% | 95.07K shares | -19.22M | $27.63 | 911.90K |
Q2 2022 | call | 0.00% | 0 shares | -1.12M | $27.63 | 41.9K | |
Q1 2022 | call | Increase | +5.54% | 2.2K shares | -44K | $54.38 | 41.9K |
Q1 2022 | share | Increase | +2.53% | 20.13K shares | -2.19M | $54.38 | 816.83K |
Q4 2021 | call | Increase | 0.00% | 39.7K shares | 2.32M | $56.3 | 39.7K |
Q4 2021 | share | Increase | +4.78% | 36.31K shares | 16.53M | $56.3 | 796.69K |
Q3 2021 | share | Increase | +26.97% | 161.50K shares | 4.64M | $39.56 | 760.38K |
Q2 2021 | share | Increase | +30.09% | 138.50K shares | -2.90M | $42.47 | 598.88K |
Q1 2021 | share | Decrease | -13.87% | -74.14K shares | -9.36M | $61.55 | 460.37K |
Q4 2020 | share | Increase | +93.09% | 257.68K shares | 27.02M | $70.54 | 534.51K |
Q3 2020 | share | Increase | +0.66% | 1.82K shares | 362K | $38.57 | 276.82K |
Q2 2020 | share | Increase | 0.00% | 275K shares | 10.31M | $37.51 | 275K |